| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Biochemistry and Graduate Institute of Medical Sciences (Y.-H.H., C.-C.W., Y.-Y.C.) School of Medicine, Taipei Medical University, Taipei 110, Taiwan; Institute of Reproductive Medicine, University of Muenster, Muenster D-48149, Germany (T.G.C., C.-H.Y.); Institute of Biological Chemistry, Academia Sinica and Institute of Biochemical Sciences (S.-T.C.), College of Science, National Taiwan University, Taipei 106, Taiwan; Institute of Pharmacology, School of Medicine (R.-B.Y.), National Yang-Ming University, Taipei 112, Taiwan; and Institute of Biomedical Sciences (B.-T.W., Y.-H.S., C.-F.T., M.-T.T., R.-B.Y.), Academia Sinica, Taipei 115, Taiwan
Address all correspondence and requests for reprints to: Dr. Ruey-Bing Yang, Institute of Biomedical Sciences, Academia Sinica, 128, Academia Road, Section 2, Taipei 11529, Taiwan. E-mail: rbyang{at}ibms sinica.edu.tw.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Biochemical and biophysical techniques involving high time resolution (approaching
10 ms) demonstrated that resact initiates a rapid and transient increase in the concentration of cyclic GMP (cGMP), followed by a transient influx of Ca2+ (6). The authors concluded that the primary motor response to the egg-derived chemoattractant was controlled by a cGMP-mediated increase in the Ca2+ concentration through, either directly or indirectly, the opening of a cGMP-gated Ca2+ channel. Likewise, starfish sperm use a similar sequence of events, but the cAMP increase is absent, again revealing that cGMP is a predominant signaling molecule in promoting Ca2+ influx (7). However, analogous ligand-receptor GC interactions have not been identified for sperm activation and chemotaxis in mammals.
To date, seven isoforms of the mammalian receptor GCs, designated GC-A to GC-G, have been cloned (8). These mammalian receptor GCs function in various physiological processes, including regulation of blood pressure, vascular regeneration, phototransduction, and fluid/electrolyte homeostasis (8). GC-A, -B, and -C function as receptors for a number of peptide hormones that stimulate cyclase activity to produce cGMP, analogous to the function of the sea urchin sperm receptor GC. Ligands for the remaining four receptor GCs have yet to be identified (9). Furthermore, none of these genes has been shown convincingly to be expressed in mammalian posttesticular sperm.
GC-G is the last member of the receptor GC family to be identified (10, 11). We have previously identified and demonstrated that mouse GC-G (mGC-G) is highly enriched in the testis (11). In this report, we further show that mGC-G is a sperm cell surface protein and investigated whether mGC-G plays a role in modulating mouse sperm motility by using an anti-mGC-G-specific neutralizing antibody.
| Materials and Methods |
|---|
|
|
|---|
Quantitative real-time RT-PCR (TaqMan) analysis
Testicular total RNAs were prepared from mice of defined postnatal ages and subjected to TaqMan analysis. Normalization involved use of glyceraldehydes-3-phosphate dehydrogenase (GAPDH) mRNA levels as described (11). The expression level of GAPDH was constant across testis samples, because the Ct values obtained by TaqMan analysis remained unchanged, at approximately 16.
Expression and purification of the ECD-immunoglobulin fusion protein
The PCR fragment coding for the entire ECD of mGC-G (residues 44472) was cloned into the mammalian expression vector pFLAG-CMV1 followed by a cDNA fragment of human IgG1 heavy chain coding for the hinge region and the CH2 and CH3 domains. The resulting expression plasmid was transiently transfected into 293T cells. Twenty hours after transfection, cells were changed to the serum-free medium for an additional 2 d. The mGC-G-IgG chimeric protein secreted into the conditioned medium was purified with use of the protein A column, and bound recombinant protein was eluted with use of the ImmunoPure gentle elution buffer.
Preparation of rabbit polyclonal antisera to mGC-G
A recombinant protein of the ECD (residues 44472) fused with human IgG Fc fragment was generated as immunogen to raise the anti-GC-G-specific antisera. New Zealand White rabbits were immunized with the recombinant protein. Each rabbit was given an initial sc injection of 0.5 mg of the recombinant protein emulsified in 1 ml of Freunds complete adjuvant. Subsequently, the rabbits received two to three booster injections of 0.25 mg conjugate with Freunds incomplete adjuvant. Antisera were recovered from blood obtained by terminal exsanguinations. The anti-ECD-specific antibody (anti-ECD Ab) was further purified on a column coupled with the recombinant protein containing the mGC-G ECD only to remove the anti-Fc antibody and, therefore, enrich the specific activity for the neutralization. The specificity of the affinity-purified anti-ECD Ab was confirmed by ELISA (data not shown).
Preparation of sperm
Outbred CD-1 mice purchased from Charles River Laboratories (Wilmington, MA) were bred in the Animal Center at Taipei Medical University, School of Medicine. Animals were handled in accordance with institutional guidelines on animal experimentations.
The culture medium used throughout these studies was modified Krebs Ringer bicarbonate HEPES medium (HM) as described previously (12). In brief, modified HM contains 120.0 mM NaCl, 2.0 mM KCl, 1.20 mM MgSO4 · 7 H2O, 0.36 mM NaH2PO4, 15 mM NaHCO3, 10 mM HEPES, 5.60 mM glucose, 1.1 mM sodium pyruvate, and 1.7 mM CaCl2. Polyvinylalcohol (1 mg/ml) was added to serve as a sperm protectant (13). The pH of the medium was adjusted to 7.37.4 with humidified air/CO2 (95:5) in an incubator at 37 C for 48 h before use (14). An amount of 90% Percoll was made isotonic by adding 1 volume of 10x HM to 9 volumes of Percoll. The 90% Percoll was further diluted with 1x HM to give 20, 40, 60, and 80% Percoll solution, which was humidified with air/CO2 (95:5) in an incubator at 37 C for 24 h before use. Mature mouse sperm were harvested by a swim-up procedure from the cauda epididymis and isolated either by centrifugation at 50 x g for 5 min, or with a 2080% Percoll gradient by centrifugation at 275 x g at room temperature for 30 min, which is especially for intracellular Ca2+ concentration ([Ca2+]i) detection and computer-assisted sperm assay (CASA). The sperm used in the present study were viable and progressively motile.
Tissue lysate preparation and Western blot analysis
Mouse testis or sperm were prepared by homogenization in modified RIPA buffer (25 mM HEPES, 125 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecylsulfate, 10 mM EDTA) supplemented with protease inhibitor cocktail (Sigma). For the most complete extraction of proteins, mouse sperm were directly lysed and boiled in Laemmli buffer. Tissue and cell debris were removed by centrifugation at 10,000 x g for 20 min at 4 C. Twenty micrograms of total protein were loaded on mini SDS-PAGE for Western blot analysis with anti-ECD Ab (10 µg/ml), followed by peroxidase-conjugated goat antirabbit IgG as previously described (15).
Detection of protein tyrosine phosphorylation
Sperm (5 x 106 cells/ml) were preincubated with anti-ECD Ab (20 µM) or rabbit IgG (20 µM) or HM (control medium) at 37 C for 15 min, and then equal volumes of BSA (0.6%) with or without the anti-ECD-Ab (20 µM) or rabbit IgG (20 µM) was added into the specified culture medium. For the control group, an equal volume of HM was added. The final concentration of BSA was 0.3%, but the concentration of the anti-ECD Ab or rabbit IgG remained unchanged. The sperm were further incubated at 37 C for 75 min, and the cell lysates were prepared for Western blot analysis as described previously (12).
Histological and cytological studies
For histological analysis, testis tissues were fixed in freshly prepared Bouins solution [0.2% picric acid, 2% formaldehyde in PBS (vol/vol)] overnight, and then dehydrated in ethanol, infiltrated, and embedded in paraffin. Each tissue section (4 µm) was mounted on a Vetabond reagent-coated slide and then dried at 55 C. Paraffin of testis sections was removed by dipping in xylene, and the sections were rehydrated through a solution of alcohol to distilled water gradient. The rehydrated sections underwent a modified antigen retrieval process to improve the immunohistochemical staining (16). Briefly, after deparaffination, tissue sections were heated in an antigen unmasking working solution (Vector Lab) to 100 C for 10 min in a microwave, and then cooled to room temperature. After the retrieval process, testis slides were washed in PBS buffer to remove the unmasking solution and then incubated in a blocking solution [5% nonfat skimmed milk in PBS (vol/vol)] at 25 C for 1 h. After a 1-h incubation, the section was washed with PBS containing 0.05% (vol/vol) Tween 20 (PBST) four times for 15 min each. The rabbit anti-ECD Ab was used as the primary antibody (10 µg/ml), and Cy3-conjugated antirabbit IgG served as the secondary antibody (1:1000). After a 1-h incubation for each antibody, the sections were washed with PBST four times. The specimens on a slide were covered with anti-fade reagent and photographed by use of a microscope equipped with epifluorescence (AH3-RFCA; Olympus, Melville, NY).
For confocal cytological analysis, freshly prepared cauda epididymal sperm were fixed in 3.7% paraformaldehyde/PBS for 30 min and smeared on a glass slide. The specimens were then incubated in the blocking solution for 1 h, then incubated with the anti-ECD Ab (10 µg/ml) as the primary Ab and FITC-conjugated antirabbit IgG as the secondary Ab (1:1000). The sperm on a slide were covered with anti-fade reagent and visualized on confocal fluorescent microscopy (Bio-Rad MRC-1000; Bio-Rad, Hercules, CA).
Flow cytometry
The intracellular calcium ion concentration, [Ca2+]i, of sperm was determined with use of fluo-3 AM by flow cytometry (FACScan; BD, San Jose, CA). In brief, Percoll-separated sperm were loaded with fluo-3 AM (10 µM) at 37 C for 10 min. After incubation, sperm were washed twice with modified HM at 50 x g for 5 min to remove any free fluo-3 AM. Fluo-3 AM-loaded sperm (106 cells/ml) were preincubated with the anti-ECD Ab (020 µM), rabbit IgG (20 µM), or HM (control medium) at 37 C for 15 min, and then equal volumes of BSA (0.6%) with or without the anti-ECD-Ab (020 µM) or rabbit IgG (20 µM) were added into the specified culture medium. In the control group, an equal volume of HM was added. The final concentration of BSA was 0.3%, but the concentration of the anti-ECD Ab or rabbit IgG remained unchanged. The sperm were further incubated at 37 C for 45 min, and [Ca2+]i content was analyzed by flow cytometry. The fluorescence of fluo-3 was excited at 488 nm and measured via a 515- to 540-nm filter. Photomultiplier tube voltages and gains were set to optimize the dynamic range of the signal. The fluorescence intensity of sperm was quantified for 10,000 individual sperm cells.
To determine the surface expression of mGC-G, Percoll-separated sperm were incubated with or without rabbit anti-ECD Ab (10 µg/ml) in blocking solution (2% FBS in PBS) at 4 C for 30 min. After the primary antibody incubation, the sperm cells were washed with HM, then incubated with FITC conjugated antirabbit IgG (1:100 in blocking solution) as the secondary antibody. The sperm cells were washed with HM again, and then fixed by 2% ice-cold paraformaldehyde/PBS and analyzed by flow cytometry.
Assay of sperm motility by CASA
Percoll-separated sperm (5 x 106 cells/ml) were preincubated with the anti-ECD Ab (7 µM), rabbit IgG (7 µM), or HM (control) at 37 C for 15 min. After the incubation, an equal volume of HM or BSA (0.6%) in the presence or absence of the anti-ECD-Ab (7 µM) or rabbit IgG (7 µM) was added (labeled as "BSA", "anti-ECD + BSA", or "rabbit IgG + BSA"), and this time point was designated as time 0. The final concentration of BSA was 0.3%, but the concentration of the anti-ECD Ab or rabbit IgG remained unchanged. The sperm were further incubated at 37 C for 30 min. At least 200 sperm cells were analyzed to monitor sperm movement characteristics. The parameters associated with the motility of sperm under different experimental conditions were determined by CASA with use of a sperm motility analyser (IVOS version 10; Hamilton-Thorne Research, Beverly, MA). A 7.0-µl sample was placed in a 10-µm deep Makler chamber at 37 C. The analyser was set as described previously (17). The accuracy of the machine in identifying motile and immotile spermatozoa was validated by use of the playback function. Fifteen fields were assessed for each sample.
Statistical analysis
All experiments were repeated at least three times with three different pooled sperm samples from four or five male mice. The data are expressed as mean ± SD. Difference in means was assessed by one-way ANOVA, followed by the Tukey-Kramer multiple comparisons test.
| Results |
|---|
|
|
|---|
|
|
|
|
Identification of testicular or sperm mGC-G by Western blot analysis
To further validate the molecular identity of mGC-G immunoreactivity, we then performed Western blot analysis with protein extracts from mouse testis and sperm. As shown in Fig. 5A
, the anti-ECD Ab recognized a testis-specific protein with an apparent molecular mass of 180 kDa, which is not seen in lysates from mouse lung, kidney, or heart (supplemental Fig. 1). This mass exceeded that of recombinant protein expressed in HEK-293T cells by more than 20 kDa, which implies that additional posttranslational modifications such as glycosylation occur in vivo. In support of this notion, Western blot analysis revealed that treatment of testis membranes with PNGaseF reduced the molecular mass of testicular mGC-G to approximately 120 kDa, which is consistent with the size of the deglycosylated core protein (supplemental Fig. 2). Again, these results confirm that mouse testis GC-G contains predominantly N-linked oligosaccharide chains. In contrast, the same Ab detected a major signal of reduced molecular mass at 48 kDa in cauda epididymal sperm (Fig. 5B
and supplemental Fig. 3). Most importantly, the anti-ECD Ab preabsorbed with immunogen resulted in no immunoreactive staining, which again supports the specificity of Ab binding.
|
Serum albumin is an abundant protein in the female reproductive tract, and it is thought to play a role in stimulating sperm processes and fertilization in vivo (21). BSA, its bovine equivalent, has been widely used to induce the [Ca2+]i influx for the study of subsequent motility, capacitation and acrosome reaction of mammalian sperm (12, 21, 27). We thus used the BSA-induced [Ca2+]i elevation as an assay to evaluate whether mGC-G participates in sperm processes. The relative [Ca2+]i reflected by the Ca2+-dependent changes in fluroscence intensity of Fluo-3 (a calcium indicator dye) was then determined by flow cytometry. Because of the lack of a known ligand or specific inhibitor for mGC-G, we used the anti-ECD Ab specifically against the entire ECD of this receptor as a neutralizing reagent in our studies (see Fig. 2
). This type of neutralizing Ab has been successfully applied to block the signaling functions of other receptor GCs (18, 19, 28).
Fluo-3-loaded sperm were first induced for Ca2+ influx by BSA (0.3%) in the absence or presence of preincubation with the anti-ECD Ab or rabbit IgG at various concentrations. As shown in Fig. 6
, incubation with BSA alone substantially increased the [Ca2+]i level, compared with the control sperm. Interestingly, preincubation followed by treatment with the anti-ECD Ab significantly inhibited the BSA-induced elevation of [Ca2+]i in a dose-dependent manner, whereas an irrelevant rabbit IgG had no effect (Fig. 6
). In addition, we have verified that incubation of the anti-ECD Ab alone (up to 20 µM) had no effect on the basal level of [Ca2+]i (88 ± 12% vs. 100%; anti-ECD Ab vs. control). Together, these results suggest that mGC-G may be involved in the upstream signaling cascade leading to increased cellular Ca2+ concentration during sperm activation.
|
To further dissect the molecular step at which mGC-G participates in the capacitation, we then examine whether mouse sperm isolated in HM (without bicarbonate) are able to mount a cAMP response by bicarbonate addition during the first minute of stimulation in the absence or the presence of the anti-ECD Ab. As shown in supplemental Fig. 5, whereas bicarbonate stimulates a marked elevation of cAMP in sperm, addition of the anti-ECD Ab or control IgG has no effect on the cAMP level. These results suggest that mGC-G may function downstream of or parallel with soluble adenylyl cyclase and upstream of tyrosine phosphorylation events during capacitation.
It has been well documented that sea urchin sperm receptor GCs modulate sperm motility and chemotaxis in response to egg-associated factors (1, 2). However, analogous ligand-receptor interactions have not been described in mammals. Because CASA is widely used to evaluate mammalian sperm parameters such as motility and velocity, we used CASA to assess the effect of the anti-ECD Ab on the motility-promoting activity of BSA in mouse sperm. As shown in Table 1
, without preincubation with the anti-ECD Ab, BSA significantly induced sperm motility (defined as the proportion of motile cells) at 30 min incubation, compared with the control sample. Interestingly, preincubation with the anti-ECD Ab greatly suppressed the BSA-induced motility to a level comparable to that in the control sample, whereas an irrelevant rabbit IgG had no effect on BSA-induced motility (Table 1
). Most importantly, the inhibitory effect of the anti-ECD Ab on BSA-induced activity was not caused by enhanced sperm agglutination. Sperm treated with BSA in the presence or absence of the anti-ECD Ab or rabbit IgG did not enhance the proportion of head-to-head agglutinated spermatozoa (data not shown). In addition, the anti-ECD Ab treatment resulted in reduced BSA-induced forward velocity evaluated by sperm kinematic parameters including average path velocity (the distance traveled along a smoothed average path divided by the elapsed time), straight line velocity (VSL, the straight-line distance from the beginning to the end of a track divided by the time taken) and curvilinear velocity (the total distance traveled by the sperm along its curvilinear path divided by the elapsed time) (Table 1
).
|
| Discussion |
|---|
|
|
|---|
One interesting observation from this study is that Western blot analysis provided evidence for proteolytic processing of mGC-G during epididymal sperm transport (Fig. 5
). Similar cellular distributions and proteolytic modifications have been reported for a number of sperm membrane proteins, such as adenylyl cyclases (31) or fertilin
/ß subunits (32). In addition, a similar proteolytic process has been described for GC-C, an intestinal receptor for Escherichia coli heat-stable enterotoxins or peptide ligand guanylin/uroguanylin (33, 34). In these studies, the proteolytic fragments of GC-C were proposed to be surface bound via inter/intramolecular disulfide bridges. Moreover, the proteolytic cleavage of GC-C did not seem to impair the functional coupling of this receptor to the cyclase activity in rat intestinal membranes. Likewise, an mGC-G fragment tethered on the sperm surface may use similar membrane-anchoring and cyclase-coupling mechanisms. On the basis of the reduced molecular mass of mGC-G, proteolytic cleavage likely occurs within its ECD in the sperm membrane. However, the exact cleavage site and the identity or the activation mechanisms of the relevant mGC-G processing components remain to be further investigated.
Because of lack of a known activator and specific pharmacological reagents, we produced a neutralizing Ab specifically against the ECD of mGC-G for functional studies. A similar approach has been repeatedly used to generate functionally blocking Abs for GC-A, -B, or -C (18, 19, 28). As shown in Fig. 6
, preincubation with this neutralizing Ab (anti-ECD) indeed inhibited BSA-induced elevation of [Ca2+]i in mouse sperm in a dose-dependent manner. In addition, preincubation of the anti-ECD Ab greatly reduced the proportion of motility, forward velocity, and the protein tyrosine phosphorylation associated with sperm capacitation induced by BSA (Table 1
and supplemental Fig. 4). The change in [Ca2+]i level coincides with the intensity of capacitation-associated protein tyrosine phosphorylation in sperm (cf. Fig. 6
and supplemental Fig. 4). Together, these results imply that mGC-G may play a role in the functional cascade leading to capacitation and motility. Because mGC-G exclusively localizes to the anterior and acrosomal region of the sperm head of mature mouse sperm, this receptor may also be involved in a signaling cascade leading to acrosome reaction. We currently are addressing these questions through a more conclusive gene-targeting methodology to further unravel the physiological functions of mGC-G in the murine system.
Our recent study showed that incubation of either the anti-ECD Ab or control rabbit IgG alone resulted in no change in the basal levels of intracellular cGMP concentrations both in mouse sperm (
1 pmol/107 sperm) or in HEK-293T cells stably expressing mGC-G (
190 pmol/105 cells). However, the sperm cGMP levels may dynamically change during the activation process and local subcellular effects caused by compartmentalization of mGC-G may not be detected by whole cell content measurements.
BSA is believed to function as a sink to remove cholesterol from the sperm plasma membrane (35, 36). Recent studies further demonstrated that BSA-mediated cholesterol efflux increases the overall membrane fluidity of the sperm plasma membrane, causing a shift of the raft-associated proteins to the nonraft domain to initiate a signaling cascade leading to subsequent sperm processes (37, 38). Although the molecular mechanism by which the anti-ECD Ab modulates the BSA-induced increase in [Ca2+]i in mouse sperm is currently unclear, the anti-ECD Ab binding may limit the BSA-mediated redistribution and thus signaling of membrane mGC-G, resulting in a downstream reduction in [Ca2+]i elevation and sperm motility. However, further studies are required to validate this hypothesis. Interestingly, the membrane proteins that control Ca2+ entry [cation channel of sperm (CatSper1 and CatSper2)] (22, 39, 40, 41) or Ca2+ extrusion [plasma membrane Ca2+ ATPase 4 (PMCA4)] (42, 43) have been recently identified to be specifically expressed in spermatozoa and linked to sperm motility. It remains to be determined whether mGC-G is indeed functionally coupled with these Ca2+ influx or efflux regulatory proteins.
Our previous study showed that all peptide ligands known to mammalian receptor GCs failed to stimulate mGC-G activity (11); therefore, mGC-G remains an orphan receptor. Because of its sperm surface expression, if mGC-G is a receptor, ligand(s) may reside within the luminal fluids of the male or female reproductive tracts. However, we do not exclude the presence of a surface-tethered ligand that functions in an autocrine fashion to activate mGC-G during sperm activation. Additional studies are required to examine the existence of such a sperm-associated activator for mGC-G.
In addition to the Ca2+ influx and efflux regulatory proteins in sperm, a number of target proteins for cGMP, such as cGMP-dependent protein kinase (PKG) (44, 45), PKG-anchoring protein (46), and cGMP-gated Ca2+ channel (47, 48), are also present in male germ cells, which raises the possibility that these proteins may represent the direct downstream target molecules for mGC-G. Alternatively, mGC-G may use other signaling mechanisms in addition to cGMP synthesis. In support of this possibility are many examples of signaling proteins possessing the kinase-like domain similar to those found in the intracellular domain of mGC-G (49).
We also observed the expression of mGC-G in the interstitial Leydig cells in addition to the predominant intratubular distribution in the mouse testis (Fig. 3
). This finding raises the possibility that mGC-G may also play an important role in this type of somatic cell. Interestingly, production of testosterone by Leydig cells has been shown to be regulated by GC-A-mediated cGMP elevation through its peptide ligand, atrial natriuretic peptide, both in vitro and in vivo (50, 51). The germ cell-enriched expression of mGC-G in the mouse testis is completely distinct from a broader tissue expression by its rat orthologue [i.e. in the lung, small intestine, skeletal muscles, and kidney (10)]. Despite multiple attempts, we were unable to detect the expression of rat GC-G in the testis even by a more sensitive method of RT-PCR amplification. Thus, it remains to be determined whether the male germ cell-specific expression of GC-G is unique to the mouse or exists in other species as well.
In summary, we have demonstrated that mGC-G is a novel sperm surface receptor and possibly functions, similar to its sea urchin counterpart, in the early signaling event that regulates the Ca2+ influx/efflux and subsequent motility response in sperm. A further understanding of the functions of this sperm receptor will provide new insights into the molecular mechanisms that regulate mammalian sperm motility and may lead to better methods of modulating motility and thus fertility.
| Acknowledgments |
|---|
| Footnotes |
|---|
Disclosure of conflicts of interest: The authors have nothing to declare.
First Published Online July 20, 2006
Abbreviations: [Ca2+]i, Intracellular Ca2+ concentration; CASA, computer-assisted sperm assay; cGMP, cyclic GMP; FITC, fluorescein isothiocyanate; GC, guanylyl cyclase; HEK, human embryonic kidney; HM, HEPES medium; mGC-G, mouse GC-G.
Received November 21, 2005.
Accepted for publication July 12, 2006.
| References |
|---|
|
|
|---|
and ß subunits, cGMP-dependent protein kinase I
and ß, and cyclic nucleotide-gated channel subunit 1 in the rat testis. J Androl 26:258263
. J Biol Chem 275:48974905This article has been cited by other articles:
![]() |
H. Lin, C.-F. Cheng, H.-H. Hou, W.-S. Lian, Y.-C. Chao, Y.-Y. Ciou, B. Djoko, M.-T. Tsai, C.-J. Cheng, and R.-B. Yang Disruption of Guanylyl Cyclase-G Protects against Acute Renal Injury J. Am. Soc. Nephrol., February 1, 2008; 19(2): 339 - 348. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |